Description: Pradaxa 150 mg capsules are an anticoagulant medication used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation and other thromboembolic disorders. Pradaxa contains dabigatran etexilate, a direct thrombin inhibitor that helps prevent the formation of harmful blood clots.
Ingredients:
- Active Ingredient: Dabigatran Etexilate 150 mg
- Other Ingredients: [List any additional inactive ingredients]
Usage Instructions:
- Dosage: Take one Pradaxa 150 mg capsule twice daily.
- Frequency: Every 12 hours.
- Special Considerations: Swallow capsules whole with a glass of water. Do not crush or chew the capsules. If a dose is missed, take it as soon as you remember unless it's almost time for your next dose. Do not double up on doses.
Benefits:
- Reduces the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.
- Lowers the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).
- Does not require routine blood monitoring, unlike some other anticoagulants.
Precautions:
- Contraindications: Not recommended for patients with active bleeding, severe renal impairment, or a history of hypersensitivity to dabigatran.
- Side Effects: May cause bleeding, gastrointestinal discomfort, or rash. In case of severe bleeding or allergic reactions, seek immediate medical attention.
- Use with caution if you have a history of bleeding disorders, liver disease, or if you are taking other medications that increase bleeding risk.
Storage Instructions:
- Store at a temperature between 15°C to 30°C (59°F to 86°F).
- Keep in a dry place, away from moisture and direct sunlight.
- Keep out of reach of children.
Manufacturer: Boehringer Ingelheim
